FRCS (ORL-HNS) · SECTION 1 SBA

Nasopharyngeal carcinoma skull-base spread

A patient with EBV-associated nasopharyngeal carcinoma develops diplopia. MRI shows cavernous-sinus extension encasing the internal carotid artery without distant metastasis. Which treatment principle is best?

CHOOSE ONE ANSWER

Best of five

  1. A. Primary open skull-base resection
  2. B. Neck dissection as sole treatment
  3. C. Radiotherapy to the nasopharynx alone without systemic therapy
  4. D. Palliative steroids only because carotid encasement precludes cure
  5. E. Definitive intensity-modulated radiotherapy with concurrent systemic therapy in a specialist MDT
ANSWER AND REASONING

E. Definitive intensity-modulated radiotherapy with concurrent systemic therapy in a specialist MDT

For non-metastatic locally advanced NPC, definitive chemoradiotherapy—not heroic resection—is the core curative strategy.

Why every option is right or wrong

A. Primary open skull-base resection: Morbidity is high and definitive chemoradiotherapy is standard for locally advanced disease.

B. Neck dissection as sole treatment: This does not treat the primary or skull-base extension.

C. Radiotherapy to the nasopharynx alone without systemic therapy: Locally advanced disease generally requires concurrent systemic treatment when fit.

D. Palliative steroids only because carotid encasement precludes cure: Carotid/cavernous extension does not automatically make non-metastatic NPC incurable.

E. Definitive intensity-modulated radiotherapy with concurrent systemic therapy in a specialist MDT: NPC is primarily chemoradiosensitive; modern target delineation must cover skull-base and nodal risk while respecting critical structures.

What if the scenario changed?

If staging demonstrated widespread metastases, systemic therapy and symptom-directed radiotherapy would replace definitive locoregional treatment alone.

EDUCATIONAL USE

Independent Clinora educational preparation material; not official JCIE content, an accredited programme, or a substitute for local policy and specialist clinical judgement.

Back to the Section 1 bank